GlassScriptPhysician profile
Kimberly Marcel
NPI 1154850204
$1,492.25
in general payments reported to CMS, 2019-2025
24 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $483 · 2024: $670 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,492.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $258.91 | 2023-2024 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $170.25 | 2024-2025 | Xyosted |
| Astellas Pharma US INC | $141.05 | 2023-2025 | Xtandi, Myrbetriq |
| Medtronic, INC. | $139.87 | 2024 | Interstim |
| Amgen INC. | $114.13 | 2024 | Krystexxa |
| Urogen Pharma, INC. | $109.59 | 2023-2025 | Jelmyto |
| Pfizer INC. | $77.49 | 2023-2025 | |
| Abc Home Medical Supply, INC. | $65.11 | 2023-2024 | |
| Progenics Pharmaceuticals, INC. | $53.47 | 2023 | Pylarify |
| 180 Medical, INC. | $53.11 | 2023-2024 | Gentlecath Glide |
| Coloplast Corp | $33.94 | 2023-2025 | Titan |
| Janssen Biotech, INC. | $29.88 | 2024 | Erleada, Akeega |
| Cumberland Pharmaceuticals, INC. | $28.39 | 2023 | Kristalose |
| Myriad Genetic Laboratories, INC. | $26.53 | 2025 | Prolaris |
| Innovation Technologies INC | $23.46 | 2024 | Irrisept |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $23.34 | 2023 | |
| Abbvie INC. | $20.41 | 2024 | |
| Convatec INC. | $19.77 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $18.85 | 2025 | Exparel |
| Boston Scientific Corporation | $18.32 | 2025 | Bulkamid |
| Organogenesis INC. | $17.87 | 2025 | Apligraf |
| Tolmar, INC. | $17.29 | 2025 | Eligard, Jatenzo |
| Hollister Incorporated | $17.02 | 2024 | |
| Photocure INC | $14.20 | 2024 | Cysview |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Marcel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.